UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Pharmacokinetics of Low Dose Ketamine Infusion

Phase 1

Terminated

Conditions: Sedation
Opioid Tolerance

Interventions: Drug: Ketamine

First Posted Date: 2008-02-20

Last Posted Date: 2016-10-26

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 5

Registration Number: NCT00618397

Locations: 🇺🇸
Children's Medical Center Dallas, University of Texas Southwestern, Dallas, Texas, United States

Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women

Phase 4

Completed

Conditions: Melasma

Interventions: Drug: 20-30% Salicylic Acid peels to the right side of the face
Drug: 20-30% Salicylic Acid peels to the left side of the face

First Posted Date: 2008-02-15

Last Posted Date: 2020-08-10

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT00616239

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, United States

Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse

Not Applicable

Completed

Conditions: Depression

Interventions: Drug: Fluoxetine
Behavioral: Relapse prevention cognitive behavioral therapy (CBT)

First Posted Date: 2008-02-11

Last Posted Date: 2016-01-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 144

Registration Number: NCT00612313

Locations: 🇺🇸
Children's Medical Center of Dallas, Outpatient Psychiatry Clinic, Dallas, Texas, United States

Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops

Not Applicable

Completed

Conditions: Dry Eye Disease

Interventions: Drug: 1st visit Optive, then 2nd visit Systane
Drug: 1st visit Systane, then 2nd visit Optive

First Posted Date: 2008-02-08

Last Posted Date: 2020-11-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT00610480

Locations: 🇺🇸
UTSW Medical Center at Dallas - Aston Ambulatory Care Center, Dallas, Texas, United States

Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Aripiprazole

First Posted Date: 2008-02-06

Last Posted Date: 2012-10-26

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 17

Registration Number: NCT00608543

Locations: 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

Role of Pancreatic Triglyceride Content in Beta-cell Function

Completed

Conditions: Type 2 Diabetes
Obesity

Interventions: Other: No intervention planned.

First Posted Date: 2008-01-28

Last Posted Date: 2017-12-26

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 101

Registration Number: NCT00602953

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Phase 3

Completed

Conditions: Porphyria Cutanea Tarda

Interventions: Drug: Deferasirox

First Posted Date: 2008-01-23

Last Posted Date: 2014-02-10

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 10

Registration Number: NCT00599326

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, United States

Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes

Phase 3

Completed

Conditions: Healthy

Interventions: Drug: Phenytoin (brand name Dilantin)
Drug: Hydrocortisone
Drug: Placebo

First Posted Date: 2008-01-11

Last Posted Date: 2015-08-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 17

Registration Number: NCT00591006

Locations: 🇺🇸
UT Southwestern Medical Center of Dallas/Parkland Memorial Hospital, Dallas, Texas, United States

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

Not Applicable

Terminated

Conditions: Type 1 Diabetes

Interventions: Drug: Glargine
Drug: Insulin detemir
Drug: NPH

First Posted Date: 2007-11-27

Last Posted Date: 2019-10-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 33

Registration Number: NCT00564018

Locations: 🇺🇸
Children's Medical Center, Dallas, Texas, United States

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: capecitabine
Procedure: adjuvant therapy
Radiation: radiation therapy

First Posted Date: 2007-11-22

Last Posted Date: 2020-08-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 50

Registration Number: NCT00562718

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy